首页医院概况医疗服务科室导航专科专家医疗技术新闻中心人事招聘
官方微信
您的位置:首页 > 新闻中心 > 媒体聚焦

《新华社》Xinhua Headlines: China's Guangdong expands nucleic acid testing to include everyone in need

2020-05-15 11:26 编辑:管理员 阅读次数:823

-- South China's Guangdong Province has been endeavoring to ensure anyone who is required to take a test or wants one can get tested for COVID-19 while accelerating its production resumption.

-- By May 11, the economic powerhouse had completed nearly 5.54 million nucleic acid tests for people with high risks of infection and its daily capacity of nucleic acid tests had reached 230,000.

by Xinhua writers Xiao Sisi, Li Laifang and Hong Zehua

GUANGZHOU, May 15 (Xinhua) -- South China's Guangdong Province had carried out 10.41 million nucleic acid tests as of Monday, covering 6.64 million people as the populous province has been on full alert against COVID-19.

The economic powerhouse has been endeavoring to ensure anyone who is required to take a test or wants one can get tested for COVID-19, amid efforts of work and production resumption.

A staff member looks at the label on a sample at a lab in Guangzhou, south China's Guangdong Province, Feb. 1, 2020. (Xinhua)

LARGE-SCALE TESTING

Every day, there are ambulances and logistics vehicles with samples for COVID-19 tests rushing to Guangzhou KingMed Diagnostics Group Co., Ltd., a leader of the independent clinical lab industry in China. The company undertakes screening tests assigned by hospitals and the government.

"Since Jan. 24, the lab at our Guangzhou headquarters has continuously conducted nucleic acid tests for over 100 days," said Cheng Yating, assistant president of KingMed and general manager of its lab management center. The group's Guangzhou lab had completed tests of more than 2 million samples by Tuesday, with a daily peak of 96,000.

As China's COVID-19 response has entered the phase of regular epidemic prevention and control after winning a decisive outcome in fighting the epidemic, the country is still taking strict measures to prevent a rebound of the coronavirus.

On April 22, a meeting of the leading group of China's COVID-19 epidemic response urged efforts to enhance the testing capability and carry out large-scale nucleic acid and antibody tests, to contribute to implementing targeted prevention and control, protecting people's health, ensuring the reasonable flow of people and comprehensively resuming work and production.

Nucleic acid testing is the prime standard to confirm COVID-19 infections, and the early diagnosis of confirmed and asymptomatic cases is conducive to blocking the spread of the virus, said an official with the Guangdong headquarters for COVID-19 prevention and control.

Staff members do nucleic acid tests at a lab in Guangzhou, south China's Guangdong Province, Feb. 13, 2020. (Xinhua)

By March, 99.2 percent of major enterprises in Guangdong had resumed operations. In April, the overall economic operations in Guangdong had reached the level of the same period last year, according to the taxation authority.

"For people who come from abroad or return to work, Guangdong has carried out mass screening via nucleic acid tests for key groups. We have done it at an early date and effectively, which plays a key role in epidemic prevention and control," said Wu Jie, with the Guangdong Provincial Center for Disease Control and Prevention.

ENHANCING TESTING CAPABILITY

By the end of Thursday, Guangdong had reported a total of 1,395 locally transmitted confirmed COVID-19 cases and 194 imported cases, with two patients still in the hospital.

To meet the needs of testing, the number of approved nucleic acid testing institutions -- hospitals, disease control, and prevention centers, and private companies -- has risen from 135 in the early phase to 251 in Guangdong. The province's daily capacity of nucleic acid tests has reached 230,000.

A staff member puts samples into a centrifuge at a lab in Guangzhou, south China's Guangdong Province, Feb. 13, 2020. (Xinhua)

Guangdong health authorities have also strengthened administration to ensure the quality of testing by third-party institutions and provided technical guidelines for them.

Businessman Ahamed Al-Yafie received nucleic acid testing near his neighborhood after returning to Guangzhou from his vacation in Malaysia three months ago.

"It is very impressive that COVID-19 has been put under control in China while the country has a population of 1.4 billion," said Al-Yafie.

Authorities in Wuhan, capital of central China's Hubei Province, said Thursday it will expand the scope of nucleic acid testing to strengthen the control of asymptomatic cases after it has already completed over 3 million nucleic acid tests. 

Xu Hongyi, Hu Nayun, and Ma Xiaoran also contributed to the reporting. (Video reporters: Xiao Sisi, Hu Nayun, Xu Hongyi, Hong Zehua; Video editor: Zheng Xin)

热点新闻
健康大讲堂
在海拔3000米的雪域高原上,他们让林芝医院泌尿外科强起来
广州市第一人民医院心血管健康联盟见成果——3家卫星医院同时获授牌
小改变,大方便!为广州市第一人民医院这波便民措施点赞~
​冬日送暖,医务社工为住院患者送上新春祝福!
发展战略升级!广州市第一人民医院进驻白云湖数字科技城倾力建设“白云模式”
“曹杰创新工作室”获评2020年广东省劳模和工匠人才创新工作室
广州市第一人民医院眼科新技术新进展学习班成功举办
广州市一医院爱心工程对口帮扶黔南州贫困先心病患儿
DIP、DRG、国家公立医院绩效考核指标与病案管理培训班成功举办
广州市第一人民医院被授予国家“高血压达标中心”
广东86家医院建成大联盟 分级应对儿童肾脏风湿病
动态|广州市医学会内科学分会2020年学术会议成功举办
广马|广州市第一人民医院的奔跑与守护
喜讯!广州市第一人民医院11位医生获评第六届“羊城好医生”
5项表彰!广州市第一人民医院获广州市抗击新冠肺炎疫情先进集体、广州市先进基层党组织称号
白云区街坊有福了!广州市第一人民医院与白云区西部医疗健康共同体来了!
第三届腔镜技能大赛获奖名单出炉,有你吗?
广州市一医院成功举办iSIM系列“模拟之路”课程
广州市第一人民医院获“中国心源性卒中防治建设基地”授牌!
广东省劳动模范甘雁妃:自己做好防护,才有能力照顾好病人!
民主管理|医院召开八届二次职代会提案专题论证会